Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: September 26, 2022

Litigation Details for Arbutus Biopharma Corporation v. Moderna, Inc. (D. Del. 2022)

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Small Molecule Drugs cited in Arbutus Biopharma Corporation v. Moderna, Inc.
The small molecule drug covered by the patents cited in this case is See Plans and Pricing .

Details for Arbutus Biopharma Corporation v. Moderna, Inc. (D. Del. 2022)

Date Filed Document No. Description Snippet Link To Document
2022-02-27 1 Complaint them. The Asserted Patents are among them: a. U.S. Patent No. 8,058,069, “Lipid Formulations…deliver nucleic acid-based medicines: U.S. Patent Nos. 8,058,069 (Exhibit A), 8,492,359 (Exhibit B), 8,822,668… COUNT 1: INFRINGEMENT OF U.S. PATENT NO. 8,058,069 65. Paragraphs 1 through 64…Arbutus’s U.S. Patent No. 9,404,127 (“the ’127 Patent”), which, like the Asserted Patents, is directed …attempted to invalidate several of the patents before the United States Patent Case 1:22-cv-00252-MSG Document External link to document
2022-05-06 17 Exhibits A-B that patent. 14. Further, Modema is a current licensee to U.S. Patent No. 8,058,069 ("…Regarding Patent And Copyright JUN 2020 Infringement 52.227-11 Patent Rights…Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in …it requires a license to its patents, including the '069 patent. Arbutus has not granted Modema…tiny-arbutus-biopharma-wins-patent- litigation-figh.aspx). 13. A finding that the '069 patent's claims External link to document
2022-02-27 3 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,058,069 B2 ;US 8,492,359 …28 February 2022 1:22-cv-00252 830 Patent Plaintiff District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.